Tag Archives: moderna stock price

On Friday, Moderna (MRNA) stock rose by 4.94% breaking out the $32 resistance level. Clinching above $34 has helped Moderna CEO Stephane Bancel to join the list of billionaires.As the war against the novel coronavirus intensifies all over the world, a lot of people are eying on the pharmaceutical companies spearheading the development of vaccines. Moderna Inc (NASDAQ: MRNA) stock continues enjoying a huge backing from investors, as the company pushes its vaccine to human testing. As a result,...

The U.S government has partnered Johnson & Johnson and Moderna to facilitate the production of the possible COVID-19 vaccine in large quantities.The government of the United States of America alongside Johnson & Johnson (NYSE: JNJ) and Moderna Inc (NASDAQ: MRNA) have partnered to produce in more substantial amounts possible vaccine for COVID-19 before the real vaccines hit the market. As per report, the U.S. government is also working to partner with not lesser than two other...

Moderna (MRNA) stock price has risen at the possibility of having a new coronavirus vaccine by the fall of this year. Trials are expected to have been completed in two months’ time.Moderna Inc (NASDAQ: MRNA) stock price has risen slightly today. The stock price is up to $28.11 +0.98 (3.61%) intraday. This rise in stock price is attributed to the expected positive results from the Moderna COVID-19 vaccine. The first results could be available in two months. Analysts believe that the trials...

As the search for COVID-19 vaccines intensifies, there are at least 20 coronavirus vaccines in the pipeline. However, Gilead Sciences (GILD) and Moderna (MRNA), the stocks of the leaders in the race, tumbled as the week came to the end.Coronavirus alias COVID-19 is the virus that has taken the humankind hostage for the past two months. It has led to most biotech companies to push beyond their limits in the search for a vaccine. As a result, the World Health Organization (WHO) officials...

Moderna (MRNA) stock tanked by 10.48% on Thursday. The slide followed FDA Stephen Huhn’s statement that the COVID-19 vaccine is at least a year away.After a short upward, Moderna Inc (NASDAQ: MRNA) stock has plunged. Yesterday, it closed at $28.27, 10.48% down from the previous mark. Before, Moderna stock had a sweet period, albeit short, accompanied by the positive coronavirus news.Moderna (MRNA) Stock PriceOn March 16, the biotech company dosed the first patient in a study of its...

Let’s have a closer look at Gilead Sciences Inc (NASDAQ: GILD) and Moderna Inc (NASDAQ: MRNA) stocks as the companies are working on possible coronavirus vaccine.In the race for a coronavirus vaccine, two horses battle for the lead, Gilead Sciences Inc (NASDAQ: GILD) and Moderna Inc (NASDAQ: MRNA). As a result, a lot of speculation on the booming of their stock prices has been in the mainstream media, since the outbreak of the deadly virus.Gilead Sciences is an American public biotech company...

As most stock markets continue bleeding out due to the coronavirus outbreak, three biotech stocks have been defying the urge as the companies are working on a vaccine or a cure for the deadly coronavirus.Three major biotech companies, which are working on developing a vaccine or cure for the deadly coronavirus, have seen their stock markets defy the overall market plunge. The select biotech companies have either announced testing the vaccine on human victims or in the process of verifying a...

On Thursday, Moderna (MRNA) stock was on a wild ride. Just in a few hours, it skyrocketed, continuing its previous growth, then halted, and fell. Now in the pre-market, it has started to gain again.Again revisiting the situation on the market which is currently so volatile that it seems impossible to keep track of all rapid changes taking place. A prime example of chaos in the stock market is Moderna Inc (NASDAQ: MRNA). On Thursday, just in a few hours, Moderna (MRNA) stock skyrocketed,...

With coronavirus outbreak spreading a lot of fears to the global investors, talks of a vaccine are bolstering the Moderna (MRNA) stock value. However, it is still an early call, as the vaccine takes over a year to go through the regulatory testing rounds.The stocks of biotechnology company Moderna Inc (NASDAQ: MRNA) rocketed approximately 23 % on Wednesday after the company announced that the progress in making another experimental vaccine for a virus tied to birth defects is going at faster...

Moderna Inc (MRNA) stock has been skyrocketing since the company announced its mRNA COVID-19 vaccine has been successfully shipped to the National Institute of Allergy and Infectious Diseases.Moderna Inc (NASDAQ: MRNA), a biotech company that is focused on drug discovery and also in the drug development, has seen its stock market value continue rising even hours after it announced the release and shipment of its COVID-19 vaccine. The shares so far are up by 7.11% in the pre-market, where at...